Charcot–Marie‐Tooth type 2A in vivo models: Current updates
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18293 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Elena Abati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Disease Models, Animal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Charcot–Marie‐Tooth type 2A (CMT2A) is an inherited sensorimotor neuropathy associated with mutations within the Mitofusin 2 ( MFN2 ) gene. These mutations impair normal mitochondrial functioning via different mechanisms, disturbing the equilibrium between mitochondrial fusion and fission, of mitophagy and mitochondrial axonal transport. Although CMT2A disease causes a significant disability, no resolutive treatment for CMT2A patients to date. In this context, reliable experimental models are essential to precisely dissect the molecular mechanisms of disease and to devise effective therapeutic strategies. The most commonly used models are either in vitro or in vivo, and among the latter murine models are by far the most versatile and popular. Here, we critically revised the most relevant literature focused on the experimental models, providing an update on the mammalian models of CMT2A developed to date. We highlighted the different phenotypic, histopathological and molecular characteristics, and their use in translational studies for bringing potential therapies from the bench to the bedside. In addition, we discussed limitations of these models and perspectives for future improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Pathophysiology and Transplantation, Dino Ferrari Center, Università degli Studi di Milano, Milan, Italy.
- Neuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
ORCID-Profile: Elena Abati, Stefania Corti
Förderung
- Ministero della Salute
Zitieren
APA
Abati, E., Rizzuti, M., Anastasia, A., Comi, G. P., Corti, S., & Rizzo, F. (2024). Charcot–Marie‐Tooth type 2A in vivo models: Current updates. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18293
Vancouver
Abati E, Rizzuti M, Anastasia A, Comi GP, Corti S, Rizzo F. Charcot–Marie‐Tooth type 2A in vivo models: Current updates. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18293
BibTeX
@article{Abati2024,
author = {Abati, Elena and Rizzuti, Mafalda and Anastasia, Alessia and Comi, Giacomo Pietro and Corti, Stefania and Rizzo, Federica},
title = {Charcot–Marie‐Tooth type 2A in vivo models: Current updates},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18293}
}
EUVIMED